Form 4 for HRMY Harmony Biosciences Holdings, Inc.
Accepted 2026-05-18 16:14:12 ET · period of report 2026-05-01 · accession 0002009762-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-18 16:14 | 2026-05-01 | HRMY | Budur Kumar | Chief MEDICAL Off | M - OptEx | $0.00 | +18.8K | 33.0K | +132% | $0 |
| D | 2026-05-18 16:14 | 2026-05-01 | HRMY | Budur Kumar | Chief MEDICAL Off | F - Tax | $31.83 | -8,882 | 24.1K | -27% | -$282.7K |
| D | 2026-05-18 16:14 | 2026-05-01 | HRMY | Budur Kumar | Chief MEDICAL Off | M - OptEx | $0.00 | -18.8K | 37.5K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-01 | M | A | 18,750 | $0.00 | 32,997 | D | — | — | (F1) The reporting person's previous Form 4 filed on January 26, 2026 inadvertently misstated the number of shares of common stock and derivatives beneficially owned following the transactions reported therein, and that the number has been corrected in the current filing. |
| 2 | Common | Common Stock | 2026-05-01 | F | D | 8,882 | $31.83 | 24,115 | D | — | — | (F2) Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date. |
| 3 | Derivative | Restricted Stock Units | 2026-05-01 | M | D | 18,750 | $0.00 | 37,500 | D | — · — to — | 18,750 Common Stock | (F3) The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. (F3) The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. (F3) The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. (F1) The reporting person's previous Form 4 filed on January 26, 2026 inadvertently misstated the number of shares of common stock and derivatives beneficially owned following the transactions reported therein, and that the number has been corrected in the current filing. |